-
Study: Low rate of cholesterol screening in children and adolescents
CHICAGO — Although some guidelines recommend lipid screening for children and adolescents of certain ages, data indicate that only about 3% are having their cholesterol tested during health visits, according to a study in the May 7 issue of JAMA, a themed issue on child health.
-
Actavis launches generic Catapres-TTS
DUBLIN — Actavis announced that it has launched a generic version of Boehringer Ingelheim's Catapres-TTS (clonidine transdermal system, USP, 0.1-mg/day, 0.2-mg/day, and 0.3-mg/day for one week), following the company's final approval on its abbreviated new drug application from the Food and Drug Administration.
Catapres-TTS is used for the treatment of hypertension. The drug had total U.S. sales of approximately $180 million for the 12 months ending Feb. 28, 2014, according to IMS Health.